Back to Search
Start Over
Clinical Trials of Metastatic Castration-sensitive Prostate Cancer: Recent Progress and New Horizons.
- Source :
-
European urology focus [Eur Urol Focus] 2019 Mar; Vol. 5 (2), pp. 165-167. Date of Electronic Publication: 2018 Dec 14. - Publication Year :
- 2019
-
Abstract
- Recent clinical trials have changed the treatment landscape for metastatic castration-sensitive prostate cancer. Ongoing and future studies using new therapeutic approaches hold the promise of further improving outcomes for patients with advanced prostate cancer.<br /> (Copyright © 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.)
- Subjects :
- Abiraterone Acetate administration & dosage
Abiraterone Acetate adverse effects
Abiraterone Acetate therapeutic use
Androgen Antagonists therapeutic use
Antineoplastic Combined Chemotherapy Protocols adverse effects
Antineoplastic Combined Chemotherapy Protocols standards
Combined Modality Therapy methods
Docetaxel administration & dosage
Docetaxel adverse effects
Docetaxel therapeutic use
Humans
Male
Neoplasm Metastasis pathology
Prostatic Neoplasms, Castration-Resistant pathology
Prostatic Neoplasms, Castration-Resistant psychology
Quality of Life
Radiotherapy methods
Steroid Synthesis Inhibitors therapeutic use
Tubulin Modulators therapeutic use
Neoplasm Metastasis therapy
Prostatic Neoplasms, Castration-Resistant secondary
Prostatic Neoplasms, Castration-Resistant therapy
Subjects
Details
- Language :
- English
- ISSN :
- 2405-4569
- Volume :
- 5
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- European urology focus
- Publication Type :
- Academic Journal
- Accession number :
- 30559064
- Full Text :
- https://doi.org/10.1016/j.euf.2018.12.001